Suppr超能文献

实体器官移植受者艰难梭菌腹泻的危险因素。

Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.

机构信息

Departamento de Medicina Interna, Hospital Universitario Puerta de Hierro, Madrid, Spain.

Biostatistics Unit, Puerta de Hierro Biomedical Research Institute (IDIPHISA), CIBERESP, Madrid, Spain.

出版信息

Transplant Proc. 2021 Dec;53(10):2826-2832. doi: 10.1016/j.transproceed.2021.09.047. Epub 2021 Nov 10.

Abstract

BACKGROUND

There is limited knowledge about risk factors for Clostridioides difficile infection (CDI) and recurrent CDI in solid organ transplant (SOT) recipients.

METHODS

A case-control study of CDI in SOT recipients compared with controls (SOT recipients who did not present CDI).

RESULTS

Sixty-seven patients from 1089 SOT recipients (6.2%) suffered at least one episode of CDI. The mean age was 55 ± 12 years and 20 cases (69%) were men. The accumulated incidence was 8% in liver transplantation, 6.2% in lung transplantation, 5.4% in heart transplantation, and 4.7% in kidney transplantation. Twenty-nine cases (43.3%) were diagnosed during the first 3 months after SOT. Forty-one cases (61.2%) were hospital acquired. Thirty-one patients with CDI presented with mild-moderate infection (46.3%), 30 patients with severe infection (44.8%), and 6 patients with severe-complicated disease (9%). Independent variables found to be related with CDI were hospitalization in the previous 3 months (odds ratio: 2.99; [95% confidence interval 1.21-7.37]) and the use of quinolones in the previous month (odds ratio: 3.71 [95% confidence interval 1.16-11.8]). Eleven patients (16.4%) had at least one recurrence of CDI. Previous treatment with amoxicillin-clavulanate, severe-complicated index episode, and high serum creatinine were associated with recurrent CDI in the univariant analysis CONCLUSIONS: Liver transplant recipients presented the highest incidence of CDI among SOT recipients. Risk factors for CDI were hospitalization in the previous 3 months and the use of quinolones in the previous month.

摘要

背景

对于实体器官移植(SOT)受者的艰难梭菌感染(CDI)和复发性 CDI,相关知识有限。

方法

对 SOT 受者的 CDI 病例对照研究,将其与对照(未出现 CDI 的 SOT 受者)进行比较。

结果

在 1089 名 SOT 受者中,有 67 名(6.2%)至少发生过一次 CDI。平均年龄为 55 ± 12 岁,20 例(69%)为男性。肝移植的累积发病率为 8%,肺移植为 6.2%,心脏移植为 5.4%,肾脏移植为 4.7%。29 例(43.3%)在 SOT 后 3 个月内确诊。41 例(61.2%)为医院获得性感染。31 例 CDI 患者感染程度为轻中度(46.3%),30 例为重度感染(44.8%),6 例为重度合并症(9%)。与 CDI 相关的独立变量为前 3 个月住院(优势比:2.99;[95%置信区间 1.21-7.37])和前 1 个月使用喹诺酮类药物(优势比:3.71[95%置信区间 1.16-11.8])。11 例(16.4%)至少有一次 CDI 复发。单变量分析中,阿莫西林克拉维酸治疗史、重度合并症指数发作和高血清肌酐与复发性 CDI 相关。

结论

肝移植受者的 CDI 发生率在 SOT 受者中最高。CDI 的危险因素是前 3 个月住院和前 1 个月使用喹诺酮类药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验